Greenleaf Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $890K | Sell |
2,730
-20
| -0.7% | -$6.52K | 0.01% | 344 |
|
|
2025
Q1 | $743K | Buy |
2,750
+28
| +1% | +$7.56K | 0.01% | 397 |
|
|
2024
Q4 | $641K | Buy |
2,722
+4
| +0.1% | +$941 | 0.01% | 446 |
|
|
2024
Q3 | $748K | Sell |
2,718
-2
| -0.1% | -$550 | 0.01% | 414 |
|
|
2024
Q2 | $661K | Sell |
2,720
-143
| -5% | -$34.7K | 0.01% | 402 |
|
|
2024
Q1 | $428K | Sell |
2,863
-75
| -3% | -$11.2K | ﹤0.01% | 516 |
|
|
2023
Q4 | $562K | Buy |
2,938
+405
| +16% | +$77.5K | 0.01% | 423 |
|
|
2023
Q3 | $449K | Sell |
2,533
-90
| -3% | -$15.9K | 0.01% | 466 |
|
|
2023
Q2 | $498K | Sell |
2,623
-137
| -5% | -$26K | 0.01% | 452 |
|
|
2023
Q1 | $553K | Buy |
2,760
+61
| +2% | +$12.2K | 0.01% | 420 |
|
|
2022
Q4 | $641K | Buy |
2,699
+24
| +0.9% | +$5.7K | 0.01% | 370 |
|
|
2022
Q3 | $535K | Buy |
2,675
+118
| +5% | +$23.6K | 0.01% | 379 |
|
|
2022
Q2 | $373K | Buy |
2,557
+181
| +8% | +$26.4K | 0.01% | 487 |
|
|
2022
Q1 | $388K | Sell |
2,376
-811
| -25% | -$132K | ﹤0.01% | 495 |
|
|
2021
Q4 | $540K | Hold |
3,187
| – | – | 0.01% | 399 |
|
|
2021
Q3 | $602K | Hold |
3,187
| – | – | 0.01% | 344 |
|
|
2021
Q2 | $540K | Buy |
3,187
+40
| +1% | +$6.78K | 0.01% | 374 |
|
|
2021
Q1 | $444K | Buy |
3,147
+29
| +0.9% | +$4.09K | 0.01% | 412 |
|
|
2020
Q4 | $405K | Sell |
3,118
-13
| -0.4% | -$1.69K | 0.01% | 385 |
|
|
2020
Q3 | $456K | Buy |
3,131
+31
| +1% | +$4.52K | 0.01% | 305 |
|
|
2020
Q2 | $459K | Hold |
3,100
| – | – | 0.01% | 294 |
|
|
2020
Q1 | $337K | Hold |
3,100
| – | – | 0.01% | 310 |
|
|
2019
Q4 | $357K | Buy |
+3,100
| New | +$357K | 0.01% | 368 |
|